Nicholas A.J. Botwood
Head of Research & Development and Chief Medical OfficerDr. Nicholas A.J. Botwood, BSc (Hons), MBBS, MFPM, FRCP, also known as Nick is Head of Research & Development and Chief Medical Officer of Syndax Pharmaceuticals, Inc. from May 12, 2025. Dr. Botwood joined the Syndax Pharmaceuticals, Inc. on May 12, 2025. Prior to joining the Company as Head of Research and Development, Chief Medical Officer, Dr. Botwood served as a consultant. Prior to joining the Company, Dr. Botwood served as Senior Vice President, Head of Worldwide Medical Oncology at Bristol Myers Squibb and previously served as Bristol Myers Squibb’s Head of U.S. Medical and Head of Oncology Clinical Development. Prior to joining Bristol Myers Squibb, he served as Head of Oncology Clinical Development and Head of Global Clinical Operations at AstraZeneca. Dr. Botwood holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Imperial College London and a Bachelor of Science (BSc) from University College London. He is a member of the Faculty of Pharmaceutical Medicine and an elected Fellow of the Royal College of Physicians UK.
Positions
- Company NameSyndax Pharmaceuticals, Inc.Stock CodeSNDXPositionHead of Research & Development and Chief Medical OfficerColleagues
- MAMichael A. MetzgerCEO & Director
- DGDennis G. PodlesakIndependent Chairman
- LJLuke J. AlbrechtGeneral Counsel & Corporate Secretary
- KAKeith Alan GoldanExecutive Officer
- SCSteven ClosterChief Commercial Officer
- PLPierre LegaultIndependent Director
- KAKeith A. KatkinIndependent Director
- JAJennifer A. JarrettIndependent Director
